Van der Plas; Steven Emiel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van der Plas; Steven Emiel.The latest application filed is for "modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use".

Company Profile

19.20.23

Van der Plas; Steven Emiel - Steenhuffel BE
VAN DER PLAS; Steven Emiel - Mechelen BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20210238159 - Altenbach; Robert J. ; et al.	2021-08-05
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders App 20210169879 - VAN DER PLAS; Steven Emiel ; et al.	2021-06-10
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,988,454 - Altenbach , et al. April 27, 2	2021-04-27
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,981,890 - Altenbach , et al. April 20, 2	2021-04-20
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,041 - Altenbach , et al. November 24, 2	2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,042 - Altenbach , et al. November 24, 2	2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,829,473 - Altenbach , et al. November 10, 2	2020-11-10
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277273 - Altenbach; Robert J. ; et al.	2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277274 - Altenbach; Robert J. ; et al.	2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277276 - Altenbach; Robert J. ; et al.	2020-09-03
Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use App 20200277275 - Altenbach; Robert J. ; et al.	2020-09-03
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,647,717 - Akkari , et al.	2020-05-12
Heteroaryl substituted pyridines and methods of use Grant 10,604,515 - Altenbach , et al.	2020-03-31
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 10,568,867 - Van der Plas , et al. Feb	2020-02-25
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors Grant 10,508,111 - Brys , et al. Dec	2019-12-17
N-Sulfonylated-Pyrazolo[3,4-b]Pyridin-6-Carboxamides and Method of Use App 20190330207 - Akkari; Rhalid ; et al.	2019-10-31
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,428,017 - Altenbach , et al. October 1, 2	2019-10-01
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20190202823 - Akkari; Rhalid ; et al.	2019-07-04
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,259,810 - Akkari , et al.	2019-04-16
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20190077784 - Altenbach; Robert J. ; et al.	2019-03-14
Heteroaryl Substituted Pyridines and Methods of Use App 20190055229 - Altenbach; Robert J. ; et al.	2019-02-21
Heteroaryl substituted pyridines and methods of use Grant 10,138,227 - Altenbach , et al. Nov	2018-11-27
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-b]pyridin-3-yl]-nicotinonitrile Derivatives And Their Use As Irak Inhibitors App 20180305351 - BRYS; Reginald Christophe Xavier ; et al.	2018-10-25
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244640 - Altenbach; Robert J. ; et al.	2018-08-30
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244611 - Altenbach; Robert J. ; et al.	2018-08-30
Substituted pyridines and method of use Grant 10,047,051 - Altenbach , et al. August 14, 2	2018-08-14
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20180221334 - VAN DER PLAS; Steven Emiel ; et al.	2018-08-09
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20180105522 - Akkari; Rhalid ; et al.	2018-04-19
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,895,347 - Van Der Plas , et al. February 20, 2	2018-02-20
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 9,890,158 - Akkari , et al. February 13, 2	2018-02-13
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,867,806 - De Blieck , et al. January 16, 2	2018-01-16
Heteroaryl Substituted Pyridines And Methods Of Use App 20170349576 - Altenbach; Robert J. ; et al.	2017-12-07
Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use Grant 9,796,711 - Akkari , et al. October 24, 2	2017-10-24
SUBSTITUTED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXYLIC ACIDS AND METHOD OF USE App 20170101406 - Akkari; Rhalid ; et al.	2017-04-13
Novel Compounds For Treatment Of Cystic Fibrosis App 20170100386 - Akkari; Rhalid ; et al.	2017-04-13
Substituted Pyridines And Method Of Use App 20160355480 - Altenbach; Robert J. ; et al.	2016-12-08
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Cystic Fibrosis App 20160317493 - VAN DER PLAS; Steven Emiel ; et al.	2016-11-03
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20160263084 - De Blieck; Ann ; et al.	2016-09-15
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,382,254 - De Blieck , et al. July 5, 2	2016-07-05
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,351,955 - Van Der Plas , et al. May 31, 2	2016-05-31
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20160022633 - VAN DER PLAS; Steven Emiel ; et al.	2016-01-28
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,133,210 - Van Der Plas , et al. September 15, 2	2015-09-15
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20150045327 - VAN DER PLAS; Steven Emiel ; et al.	2015-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.